2A Pharma
PrivateLast Round
Grant
Sep 27, 2018
Total Funding Raised
$5.96M
Company Overview
2A Pharma operates in Healthcare & Life Sciences and is based in Malmö. Its latest recorded funding round was a Grant round in September 2018.
2A Pharma is a biopharmaceutical company that develops novel prophylactic and therapeutic vaccines using its proprietary adeno-associated virus-like particle (AAVLP) platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
2A Pharma Comparables
Compare 2A Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VLP Therapeutics | 83% | |
| PathoVax LLC | 79% | |
| PapiVax Biotech, Inc. | 77% |
For institutional investors. Book with your work email.
2A Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 27, 2018 | ||||
| Seed | Jun 25, 2018 | ||||
| Seed | Dec 20, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
2A Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| Vinnova | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 40% MoM.
- Mar 4, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
2A Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 2A Pharma's valuation, stock price, and market status.
Is 2A Pharma a public or private company?
2A Pharma is a private company.
What is the current stock price of 2A Pharma?
2A Pharma is a private company, so its shares have no public market price. Caplight tracks 2A Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 2A Pharma worth (valuation)?
Valuation information for 2A Pharma is not publicly available.
Can I buy 2A Pharma stock?
2A Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 2A Pharma's last funding round?
2A Pharma's most recent funding round was Grant on September 27, 2018.
Who are the main investors in 2A Pharma?
Key investors in 2A Pharma include Innovation Fund Denmark, Eurostars SME programme, Vinnova.
Will 2A Pharma IPO soon?
No public IPO plans have been announced for 2A Pharma.
How can I track 2A Pharma secondary market activity?
Caplight tracks bids, offers, and trades in 2A Pharma's shares on secondary markets.